The Vice Chancellor-Prof. Barnabas Nawangwe (Centre) and Principal CHS-Prof. Bruce Kirenga (Green Cap) with some of the 16 PHO Fellows at the Award Ceremony on 30th July 2025.
Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH), established the Paediatric Haematology and Oncology Fellowship (PHO) Program to build capacity and strengthen care for children with cancer and blood disorders across the country and the region.
Since its inception in 2016, 24 pediatricians have been trained by the program and now serve as leaders in Paediatric Haematology and Oncology clinical services across ten hospitals in seven countries in Africa. This marks a remarkable transformation from just two trained paediatric oncologists in Uganda in 2016 and has contributed to significantly improved survival rates for children with cancer and blood disorders.
On the 30th July 2025, 16 Fellows of the PHO Fellowship received their awards after a two-year stint on the fellowship. Below are their profiles
2018/2020 Cohort
Dr. Nana Nakiddu is a Paediatric Haematologist and Oncologist and lecturer at Muhimbili University of Health and Allied Sciences/Muhimbili National Hospital in Tanzania. Her career focus is on developing innovative models for the delivery of childhood cancer survivorship care in low- and middle-income countries, particularly in sub-Saharan Africa, where cancer survivorship care is still in its early stages despite major advancements in access to diagnosis and treatment. Her ultimate career goal is to lead research and care initiatives for the growing population of childhood cancer survivors across Africa. She is passionate about sports and has represented Uganda internationally in swimming. As a qualified sports medicine physician, she contributes to the field both nationally and globally. She currently serves as the Secretary General of the Uganda Society for Sports Medicine and is the immediate past chairperson of the Uganda Olympic Committee’s Medical and Anti-Doping Commission.
Dr. Heronima Joas Kashaigili is a Pediatric Hematologist and Oncologist at Bugando Medical Centre and a lecturer Catholic University of Health and Allied Sciences in Mwanza Tanzania. She is the Assistant Head of Oncology Services and leads the Pediatric Hematology and Oncology Unit at Bugando Medical Centre. She is recognized nationally as a mentor and leader in advancing pediatric cancer care to improve survival outcomes through capacity-building initiatives.
Dr. Kashaigili earned her medical degree from the Catholic University of Allied and Health Sciences in 2009. She specialized in Pediatrics and Child Health at Kilimanjaro Christian Medical College in 2017 and completed a fellowship in Pediatric Hematology and Oncology at Makerere University College of Health Sciences in 2020 with support from the Texas Children’s Global HOPE program. She also has training and experience in clinical research and is currently pursuing a Master of Science in Global Child Health (MSGCH).
Dr. Deborah Omeddo is a Paediatric haematologist and oncologist at Kisii teaching and Referral hospital and an adjunct lecturer at both the Kenya Medical Training college and Kisii University in Kenya. She has practiced as a paediatrician for the last 15 years during which she has keenly participated in research and clinical care of children. She has a passion for childhood haematological care and especially in Sickle cell disease. She has been a keen advocate for access of affordable care for sickle cell disease patients and is a patron of a number of the Sickle cell disease foundations. She has served in the Kenya paediatric association board where she advocated for childhood malnutrition and access to nutritional supplements. She is a member of the Kenyan ministry of health technical working group on childhood cancer where she has participated in development of management policy and guidelines. Her career goal has been to improve the research and clinical management of Sickle cell and other haematological disorders among children in sub-Saharan Africa.
Dr. Anne Akullo is a Pediatric Hematologist and oncologist and the current President of the Uganda Pediatric Association. She is the Associate Director of Clinical Operations for the Texas Children’s Hospital Global HOPE (TCH-GH) supported programs in Africa, where she leads the Dissemination and Implementation Science program. She is passionate about advocacy for child health and uses the UPA platform to promote high-impact policies for child health initiatives, such as the scale-up of sickle cell disease care on a national scale. Dr. Akullo completed her medical degree from Makerere University College of Health Sciences in 2005, followed by a specialization in Paediatrics and Child Health at Makerere University College of Health Sciences in 2014. She completed a Fellowship in Pediatric Hematology and Oncology at the same institution in 2020, supported by Texas Children’s Global HOPE. In addition, she has training and experience in Project Management, Implementation Science, and child health advocacy.
Dr. Irene Nzamu is the Head the Pediatric Haematology and Oncology Unit at Kenyatta National Hospital (KNH) and an honorary lecturer in the Department of Paediatrics in the University of Nairobi. Dr. Nzamu chairs the Hospital Blood Transfusion Committee and is deputy chair of the Hospital Ethics Committee. Nationally, Dr. Nzamu is the paediatric lead in the Focal Team for the Kenya National Cancer Control Strategy, is a member of the Ministry of Health’s Technical Working Group on Childhood Cancer and is actively involved in the establishment of the Kenya Pediatric Hematology and Oncology Society. She has served as Treasurer in the Kenya Society of Hematology Oncology (KESHO).
She earned her both her undergraduate and post graduate degrees from the University of Nairobi in 2005 and 2012 respectively. She completed the clinical fellowship in pediatric hematology and oncology training at Makerere University College of Health Sciences supported by Texas Children’s Global HOPE in 2020. She is a graduate of the African Leadership University Public Sector leadership fellowship and has undertaken several trainings from the University of Washington. She is passionate about providing evidence-based childhood cancer care targeting to bridge the gap in survival for children in Low Middle-Income Countries.
Dr. Ankunda is a Pediatric Hematologist and Oncologist based at the Cancer Center of Mbarara Regional Referral Hospital (MRRH) in Western Uganda. She previously served as a lecturer in the Department of Pediatrics and Child Health at Kabale University. She has spearheaded numerous childhood cancer awareness campaigns and conducted research focused on understanding the reasons for treatment abandonment among children with cancer. Her research interest is in solid tumors with a focus on understanding their biology in sub-Saharan Africa and improving the survival of children affected by solid tumors.
Dr. Ankunda earned her medical degree from Makerere University College of Health Sciences in 2010, followed by a specialization in Paediatrics and Child Health at Mbarara University of Science and Technology in 2017. She completed a Fellowship in Pediatric Hematology and Oncology at Makerere University College of Health Sciences in 2020, supported by Texas Children’s Global HOPE.
2019/2021 Cohort
Dr. Innocent Adebayo graduated with a medical degree (MBBS) from the University of Ilorin, Nigeria in 2006 and completed his residency in Paediatrics at the University of Abuja Teaching Hospital in 2018 with a Fellowship in Paediatrics (FMCPaed). Dr Adebayo’s completed his Paediatric Haematology and Oncology Fellowship Training in in 2021 from Makerere University College of Health Sciences, supported by the Texas Children’s Hospital Global HOPE program. He recently, in 2024, obtained a Fellowship in Palliative Medicine from the Institute of Palliative Medicine in India/St Christopher’s Hospice in London, United Kingdom. Dr Adebayo’s areas of interest are newborn screening, disease severity and hematopoietic stem cell transplantation in Sickle Cell Disease.
Dr. Rizine Mzikamanda is a specialist consultant in Pediatrics and Pediatric Hematology and Oncology at Baylor College of Medicine Children’s Foundation Malawi and Malawi National Cancer Center at Kamuzu Central Hospital (KCH). He is the Medical Director of the Global Hematology Oncology Pediatric Excellence Program in Malawi.
Dr. Mzikamanda completed his medical degree at the University of Malawi, College of Medicine (now Kamuzu University of Health Sciences- KUHES) in 2010, specialization in pediatrics at the University of Malawi, College of Medicine and University of Pretoria in 2018, and pediatric hematology and oncology fellowship at Makerere University in 2021 supported by Texas Children’s Global HOPE.
His vision is to become one of the leading clinical researchers in childhood leukemia and lymphoma in Sub-Saharan Africa (SSA). He is interested in developing locally appropriate treatment strategies for children in SSA and leading clinical trials in childhood cancer in this region over the next 5-10 years.
Dr. Catherine Muendo is a paediatric haematologist and oncologist working at the paediatric hematology and oncology department in Kenyatta National Hospital, Nairobi, Kenya. She is the head of unit at the Hemophilia comprehensive care centre at Kenyatta National Hospital. She is the vice chair of the Paediatric Hematology Oncology Society of Kenya.
She completed her medical degree at the University of Nairobi in 2010, and specialized training in paediatrics and child health at the University of Nairobi in 2017. She completed her paediatric hematology and oncology fellowship training at Makerere University College of Health Sciences, supported by Texas Children’s Global HOPE in 2021
Dr. Emma Nsalazi Bambi is a Congolese paediatrician and subspecialist in paediatric haematology and oncology, currently pursuing a Clinical Fellowship in Transfusion Medicine at McMaster University in Hamilton, Ontario, Canada. He holds a Master of Medicine in Paediatrics and Child Health from Makerere University, Uganda, and completed fellowship training in Paediatric Haematology and Oncology at Makerere University College of health Sciences Texas Children’s Global HOPE.in 2021.Dr. Bambi began his medical career after obtaining his Doctor of Medicine degree from Goma University in the Democratic Republic of Congo, and specialized training in pediatrics and child health at Makerere University.
Dr. Annet Nakirulu completed her medical degree (MBChB) at Kampala International University in 2012, higher diploma in Paediatric palliative care at Mildmay Uganda in 2016, specialization in paediatrics at Uganda Martyrs University Post graduate School Nsambya in 2019 and pediatric hematology and oncology fellowship at Makerere University College of Health Sciences in 2021
Dr. Annet Nakirulu is an associate consultant in Pediatric hematology at the Directorate of Pediatrics at Mulago National Referral Hospital. She provides evidence-based interdisciplinary medical care to children with sickle cell disease, plans and leads Paediatric Hematology Oncology education and outreach activities within the local and national community. She also participates in research, clinical quality improvement and program monitoring and evaluation activities for children with cancer and blood disorders at Mulago National Referral Hospital in collaboration with Texas Children’s Hospital Global HOPE Program.
Dr. Moses Karashani began his medical journey at China Medical University, where he received comprehensive training in general Paediatrics and Child health. Driven by a passion for advancing care in childhood blood disorders, he pursued a fellowship in Paediatric Haematology and Oncology at Makerere University College of Health Sciences Texas Children’s Global HOPE, completing it in 2021
Currently, Dr. Karashani serves at the Muhimbili National Hospital, Mloganzila campus in Tanzania. His clinical and research interests focus on the management of both benign and malignant haematologic conditions in children, aiming to improve outcomes through evidence-based approaches and targeted therapies. His work bridges the gap between bedside care and academic inquiry, making him a vital contributor to Tanzania’s growing Paediatric haematology and oncology landscape.
Cohort 2020/2022
Dr. Rose Munge is the Head of Unit -Paediatric Haematology and Oncology at Kenyatta University Teaching, Research and Referral Hospital (KUTRRH) and a lecturer in the Department of Paediatrics at Mount Kenya University. Dr. Munge played a key role in establishing paediatric oncology services at KUTRRH, culminating in the successful commissioning of the unit in 2024. She is also an active member of the Ministry of Health’s Technical Working Group on Childhood Cancer and is actively involved in the establishment of the Kenya Paediatric Haematology and Oncology Society. She earned her medical degree from the University of Nairobi in 2008 and completed specialized training in paediatrics at the same institution in 2015. In 2023, she completed a clinical fellowship in paediatric haematology and oncology at Makerere University College of Health Sciences supported by Texas Children’s Global HOPE. She also holds additional training in healthcare leadership from the University of Washington. Dr. Munge is passionate about expanding local fellowship training opportunities in paediatric haematology and oncology and is committed to advancing research-driven, high-quality cancer care for children across Kenya.
Dr. Catherine Nabaggala is a Paediatric Haematology and Oncology Specialist at Global HOPE (Haematology-Oncology Paediatric Excellence) Program in Uganda, based at Mulago National Referral Hospital. Dr Nabaggala completed her medical degree at Makerere University in 2004, specialized in Paediatrics at Makerere University Medical School in 2013 and Paediatric Haematology and Oncology fellowship at Makerere University in 2023 supported by Texas Children’s Global HOPE. Her vision is to scale up essential care for children with haematological disorders especially Sickle cell disease to the most vulnerable children living in primary health care settings.
Dr. Jennifer Zungu is the Director of The Texas Children’s Global HOPE program in Uganda. She holds a Bachelor of Medicine and Bachelor of Surgery from Makerere University, a Master of Medicine in Paediatrics and Child health from Mbarara University of Science and Technology (MUST), and a Diploma in Health care Management from The Kenya Institute of Management (KIM). She completed her clinical fellowship training in paediatric haematology and Oncology at Makerere University Supported by Texas Children’s Global HOPE.
Dr. Zungu is passionate and deeply committed to, driving better outcomes in Paediatric Haematology and Oncology. She uses her experience in healthcare management along with her clinical training in Paediatric Haematology-Oncology to advocate for evidence-based paediatric haematology and oncology care, best quality services, and excellent customer experience in the Public Healthcare sector in Uganda and beyond.
Dr. Joseph Gore is Head of the Pediatric Hematology & Oncology Unit at Alsabbah Children Hospital in Juba, and Senior Lecturer at the University of Juba, with a focus on improving sickle cell disease care & oncology services in South Sudan.
A joint study between Makerere University School of Public Health (MakSPH) and The Open University, UK, is investigating a possible link between maize cultivation and malaria risk in Uganda, as evidence increasingly points to livelihoods and everyday economic activities as key drivers of transmission of the disease.
The research initiative was advanced during a stakeholders’ workshop held on April 15, 2026, at MakSPH’s Resilient Africa Network in Kololo, where a team led by Assoc. Prof. David Musoke of Makerere University and Dr. Kevin Deane of The Open University presented ongoing and previous findings on the social determinants of malaria. The meeting brought together academics, policymakers, and practitioners to examine how agricultural practices, particularly maize farming, may be shaping malaria patterns in both rural and urban settings in Uganda.
The work builds on a growing body of research linking malaria to economic activity. One such study, led by the two researchers and published in Global Public Health in December 2025, found that livelihood activities such as farming, livestock keeping, and night-time work significantly influence malaria exposure. The study identified agriculture, especially maize cultivation near homes, as a key factor associated with increased mosquito density and heightened infection risk.
Assoc. Prof. David Musoke presents research findings on how livelihoods, including maize cultivation near homes, may influence malaria exposure during a stakeholder workshop at the Resilient Africa Network, Kololo, on April 15, 2026.
At the workshop, Dr. Musoke said the new inquiry reflects a broader shift in how malaria is understood, outlining how livelihoods, particularly agriculture, shape exposure through multiple pathways, from crop production and water use to the timing of daily activities that coincide with peak mosquito biting hours. These patterns, he argued, extend risk beyond what conventional interventions, such as insecticide-treated nets and indoor spraying, are designed to address.
Uganda remains one of the countries most affected by malaria, with the disease accounting for a significant share of outpatient visits, hospital admissions, and deaths. It is consistently ranked among the leading causes of illness and mortality, particularly among children under five and pregnant women. Despite sustained investment in prevention and treatment, including widespread distribution of insecticide-treated nets and indoor residual spraying, transmission remains high in many parts of the country. This persistence has increasingly drawn attention to factors beyond conventional interventions, including the role of livelihoods, environment, and everyday exposure to mosquitoes.
Maize grown close to homes, with damp ground conditions, may increase exposure to malaria in rural communities.
“As researchers, our role is to generate evidence, and that evidence should inform decision-making,” Dr. Musoke said. “We do not work in isolation. What we hear from stakeholders matters. We are bringing together different sectors, disciplines, and institutions because this work is still in progress, and we intend to build it collaboratively. Increasingly, research requires not just academics, but policymakers, implementers, and communities to be part of the process.”
The collaboration with The Open University has been central. Dr. Deane said the idea of examining the relationship between maize and malaria emerged from several years of joint research on social determinants with MakSPH. He pointed to a gap in malaria research, which has largely focused on biomedical and indoor interventions, while overlooking the role of livelihoods and outdoor exposure.
Assoc. Prof. David Musoke (left), Dr. Paul Mulumba (centre), a Health Inspector in Wakiso District, and Dr. Kevin Deane (right) share insights during the workshop at the Resilient Africa Network, Kololo, on April 15, 2026.
“We cannot continue relying solely on bed nets, spraying, and treatment,” Dr. Deane said. “These remain essential, but they are not sufficient for elimination. There is significant outdoor malaria transmission, particularly among adults, and that is linked to how people live and work.”
He added that maize presents a complex case. As one of Uganda’s most widely grown staple crops, it is central to both food security and household income, making it impractical to separate farming from living spaces. This, he said, underscores the need to better understand the relationship and develop responses grounded in evidence and local realities.
Evidence presented during the workshop drew on both community experiences and existing scientific literature. Prior qualitative research by the team found that mosquito populations increase during maize growing seasons, particularly in the evenings. Scientific studies also show that maize pollen can enhance mosquito survival and longevity, potentially increasing their capacity to transmit malaria.
Dr. Kevin Deane of The Open University emphasised the need to move beyond conventional malaria interventions to better understand how livelihoods and everyday activities shape exposure during the stakeholder workshop in Kololo, Kampala, on April 15, 2026.
Previous work in Wakiso district further situates maize within a wider set of risk factors. Findings show that agriculture, including crop production and animal husbandry, can create conditions that support mosquito breeding through stagnant water, water storage practices, and environmental changes. These risks are compounded by outdoor activities in the early morning and evening, when exposure is highest. The research also points to the growing role of urban agriculture, which is bringing crop cultivation and potential mosquito habitats closer to residential spaces, altering traditional patterns of transmission.
Ms. Doreen Nabwire Wamboka, in-charge at Namayumba Epicentre Health Centre III in Wakiso District, said the discussions challenged long-held assumptions that malaria is a “well-understood” condition.
“I used to think malaria had been fully researched, that we already knew what we needed to know,” she noted. “I now see that what has been studied is the conventional side of it. There are emerging factors we have not paid attention to. This work is opening up new ways of thinking, even about things we take for granted, like the crops we grow around our homes. We treat malaria as ordinary, yet it is still one of the most common conditions. Understanding these connections could change how we approach the disease.”
Ms. Doreen Nabwire Wamboka, In-charge at Namayumba Epicentre Health Centre III in Wakiso District, engages in a co-creation session as a fellow participant looks on during the stakeholder workshop in Kololo on April 15, 2026, underscoring the need for collaborative approaches to design interventions to tackle malaria.
The initiative will now combine spatial analysis, entomological studies, and community-based research to better understand how maize cultivation influences malaria risk. It will also involve farmers and other stakeholders in shaping potential interventions, reflecting a broader shift toward co-produced solutions.
The workshop, funded by The Open University, marked an important step in refining this research agenda. As the work progresses, its findings could inform policy and practice not only in Uganda, but also in other malaria-endemic countries where maize is widely cultivated. For now, the research signals a shift from isolated interventions to a more integrated understanding of how livelihoods and environments drive malaria transmission.
Update: Application deadline extended to 30th April 2026
Makerere University School of Public Health (MakSPH) is pleased to announce the Certificate Course in Water, Sanitation and Hygiene (CWASH) – 2026.
This intensive and practical short course is designed to strengthen the knowledge, skills, and attitudes of professionals involved in the planning, implementation, and management of Water, Sanitation and Hygiene (WASH) services. The programme responds to the growing demand for competent WASH practitioners in local government, non-governmental organisations, and the private sector.
Course Highlights
Duration: 8 weeks (01 June – 24 July 2026)
Mode: Day programme (classroom-based learning and field attachment)
Fees:
UGX 900,000 (Ugandans / East African Community)
USD 500 (International participants)
Application deadline:Thursday, 30 April 2026
Who Should Apply?
Practising officers in the WASH sector
Environmental Health workers seeking Continuous Professional Development (CPD)
Applicants with at least UACE (or equivalent) and one year of WASH-related work experience
Attached to this announcement, interested persons will find:
The course flier, providing comprehensive programme details, and
The application form, which should be completed and returned to MakSPH together with the required supporting documents.
For full course details, application procedures, and contact information, please carefully review the attached documents. Eligible and interested applicants are strongly encouraged to apply before the deadline and take advantage of this opportunity to build practical competence in WASH service delivery.
Makerere’s School of Public Health (MakSPH) is expanding faster than it can house itself. It now hosts more than 1,000 students, runs programmes across multiple countries, and anchors a large share of the University’s research output. Yet parts of its operation still spill into rented space, costing over $113,000 a year, because the infrastructure has not kept pace with its growth.
That constraint sits uneasily with the School’s economic weight. Health research accounts for more than half of Makerere University’s academic output, making it one of the University’s most productive engines. As Vice Chancellor Barnabas Nawangwe put it, “An educated population is a healthy population, and an educated and healthy population is a prosperous population.”
Beyond the university, health is not just a social outcome but a driver of economic performance. Healthier populations are more productive, more resilient, and less costly to sustain. Investments in public health, whether in prevention, systems, or infrastructure, raise an economy’s productive capacity, not just improve outcomes.
A construction worker undertakes metal fabrication works at the Makerere University School of Public Health (MakSPH) building site.
Institutions that generate public health knowledge and train professionals are not peripheral to growth; they are part of its foundation.
It is this logic that is shaping how Makerere’s School of Public Health is positioning itself. At its centre is a new, unfinished complex on the University’s main campus, intended to anchor the School’s next phase as a regional hub for research, training, and policy support. But like much of the system it supports, it is being built gradually, in a “build-as-you-go” approach constrained as much by funding realities as by design.
Construction of Phase II of the MakSPH complex is now at an advanced stage, with progress recorded across all sections of the site. As of March 2026, Phase 2B is nearing completion at 98%, while Phase 2A stands at 89%, and Phase 2C at 69%, each tracking close to or slightly ahead of planned targets. Current works are concentrated on interior finishes—including tiling, terrazzo installation, and external rendering—as well as preparations for lift installation, signaling a transition from structural works to final detailing. The project team is working toward a practical completion date of August 31, 2026, with timelines calibrated to align with broader resource flows and implementation considerations.
Six years ago, in February 2020, construction began on what will be the new home of the School of Public Health. The building, a permanent, purpose-built public health facility on Makerere’s main campus, will accommodate a growing student body, provide space for doctoral and postdoctoral fellows, and strengthen the University’s ability to respond to Africa’s most pressing public health challenges.
Professor David Serwadda, Professor Emeritus at Makerere University and Chair of the MakSPH Infrastructure Fundraising Committee, said the construction journey reflects the School’s “ambition, intent, and courage”—a bold step despite limited resources. He was speaking at a public lecture on health financing held at Makerere University on April 9, 2026.
But the ambition behind the project is not modest. “We are not building for today—we are building for the future,” said Professor David Serwadda, reflecting on a decision that shaped the entire construction effort. “We need to build for the next 100 years.”
Professor David Serwadda, Professor Emeritus at Makerere University and Chair of the MakSPH Infrastructure Fundraising Committee, speaks at a public lecture on health financing for Uganda’s future, held on April 9, 2026.
That long view helps explain both the scale of the project and the risks taken to start it. When construction began, the School did not have the full funding. “We started with about a third of the required budget,” Serwadda said.
The approach was not without setbacks. A major grant from USAID, worth over a million dollars, was later withdrawn, midway through the construction, due to the closure of USAID. “We received what is called a ‘Dear John letter,’” he recalled. “At that moment, we felt the situation was a major blow, almost terminal for the project.”
But the project did not stop. It adjusted. “We said, let us continue, piecemeal,’” he said. “Finish the auditorium first, use it, and keep building the rest.”
“We have come a long way as the School of Public Health,” said Professor Rhoda Wanyenze, the Dean. “We are proud of that history, but we also recognize that it comes with responsibility.”
Professor Rhoda Wanyenze, Dean of the Makerere University School of Public Health, speaks at a public lecture on health financing for Uganda’s future, held on April 9, 2026.
She argued that responsibility is no longer confined to Uganda. With ongoing collaborative work in more than 25 African countries currently, the Dean says this is “a responsibility to provide leadership in public health not only in Uganda but across the continent.”
The scale of that growth has been visible from what was once a small training unit in the Faculty of Medicine in the 1950s, which has expanded into 12 academic programmes and more than 1,000 students.
“When I came back for my public health training, we were about 40 students,” she said. “Now, we have more than 1,000.” “Public health is growing and evolving,” Wanyenze said. “And we are doing our best to develop the skills needed for this changing landscape.”
That includes new areas such as health informatics and data science, driven by the digitisation of health systems and the growing role of data in decision-making and AI. The School is already coordinating regional platforms on digital health, linking multiple countries in shared learning and practice.
But this growth has outpaced the physical systems needed to sustain it. For the University leadership, the implications extend beyond infrastructure.
“One of the most effective ways to invest in health in Uganda is to invest properly in Makerere University,” said Vice Chancellor Barnabas Nawangwe. “We must recognize Makerere as a research-led university with a special national role—not fund it like any other institution or department. Makerere is one of the government’s greatest assets. Invest in her, and the returns will exceed expectations.”
Professor Nawangwe hailed Dr. Ramathan Ggoobi, the Permanent Secretary to the Treasury, who delivered a keynote on investing in health for Uganda’s future in view of Vision 2040. “I wish to thank Dr. Ramathan Ggoobi and his team for their personal intervention in allocating resources in next year’s budget to complete the new School of Public Health building. That support is deeply appreciated,” he said.
Vice Chancellor Professor Barnabas Nawangwe speaks at a public lecture on health financing for Uganda’s future on April 9, 2026.
Uganda’s progress in health outcomes is evident, but uneven. Life expectancy has risen significantly from about 50 years in 2000 to roughly 68.8 years in 2024, according to the Permanent Secretary to the Treasury, Ramathan Ggoobi. Yet the gains sit alongside persistent financial strain on households. About 4% of Ugandans still spend more than a quarter of their consumption on healthcare, pushing many into poverty as a result of illness.
For Ggoobi, this points to a structural gap that recurrent government spending alone cannot close. “We must mobilise long-term domestic capital without adding fiscal risk,” he argued, pointing to the need for more sustainable financing mechanisms. Central to this is the gradual design and rollout of a national health insurance scheme. Evidence from countries such as Rwanda, Kenya, and Ghana suggests that well-structured contributory models can expand coverage while reducing catastrophic out-of-pocket spending.
“My Ministry and the School of Public Health must be partners. … Evidence framed in fiscal terms drives policy,” said Ggoobi, stressing the need for locally grounded solutions. “What works in Ghana might not work here. We need a model that fits Uganda.”
Uganda’s current macroeconomic conditions, relatively low inflation, currency stability, and expanding private credit may provide a window to move in that direction.